US Tariffs on Drugs: Sun Pharma Faces Limited Impact

The US is placing a high tax on certain imported medicines, specifically those with brand names and patents.

This could affect some Indian drug companies.

Sun Pharma is the most exposed among Indian companies, but the financial impact may be limited.

This is because most Indian pharmaceutical exports to the US are generic drugs which are not affected.

Companies with US manufacturing plants are exempt, which could lead to some companies shifting production to the US to avoid the tariffs.